APA

Mittendorf E. A., Ardavanis A., Symanowski J., Murray J. L., Shumway N. M., Litton J. K., Hale D. F., Perez S. A., Anastasopoulou E. A., Pistamaltzian N. F., Ponniah S., Baxevanis C. N., von Hofe E., Papamichail M. & Peoples G. E. (20171227). Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Mittendorf E A, Ardavanis A, Symanowski J, Murray J L, Shumway N M, Litton J K, Hale D F, Perez S A, Anastasopoulou E A, Pistamaltzian N F, Ponniah S, Baxevanis C N, von Hofe E, Papamichail M and Peoples G E. 20171227. Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Mittendorf E. A., Ardavanis A., Symanowski J., Murray J. L., Shumway N. M., Litton J. K., Hale D. F., Perez S. A., Anastasopoulou E. A., Pistamaltzian N. F., Ponniah S., Baxevanis C. N., von Hofe E., Papamichail M. and Peoples G. E. (20171227). Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Mittendorf E A, Ardavanis A, Symanowski J, Murray J L, Shumway N M, Litton J K, Hale D F, Perez S A, Anastasopoulou E A, Pistamaltzian N F, Ponniah S, Baxevanis C N, von Hofe E, Papamichail M and Peoples G E. Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence. : Annals of oncology : official journal of the European Society for Medical Oncology. 20171227.